BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 5, 2005
View Archived Issues
FDA Turns Down Orathecin, Reviews NDA For Dacogen
Bad tidings from the FDA regarding SuperGen Inc.'s Orathecin for pancreatic cancer overshadowed positive (if expected) news about the company's Dacogen for myelodysplastic syndromes, partnered with MGI Pharma Inc. (BioWorld Today)
Read More
Nereus, Vitae Raise Funds For Clinical Trials In 2005
Read More
Insmed Submits SomatoKine NDA, Faces Legal Challenge
Read More
DOR's OrBec Misses In Phase III, But Stock Rises On Mortality Rate
Read More
Other News To Note
Read More